/clinical/,/clinical/tools-resources/,/clinical/tools-resources/lab-test-directory/,/clinical/tools-resources/lab-test-directory/molecular-diagnostics/,

/clinical/tools-resources/lab-test-directory/molecular-diagnostics/name-67740-en.labtest

Jun 16, 2017

page

100

UWHC,UWMF,

Clinical Hub,Tools & Resources,UWHC Lab Test Directory,Molecular Diagnostics

CMV Qualitative by PCR, BAL

CMV Qualitative by PCR, BAL (HCCMVBAL) Molecular Diagnostics Lab Test

Name: CMV Qualitative by PCR, BAL

Test Name: CMV Qualitative by PCR, BAL

Health Link Test Code: HCCMVBAL

LIS Test Code: CMVBAL

CPT Code(s): 87496

Methodology: Real-Time PCR

Clinical Information:

Detect CMV in bronchoalveolar lavage.

Days Performed: Mon-Fri.

In-Lab Turnaround Time: 2 - 3 days.

Stat In-Lab Turnaround Time: Not available stat.

Specimen: Bronchoalveolar lavage (BAL)

Collection Volume: 50 mL

Pediatric Collection Volume: 12 mL

Stability Ambient:

72 hours

Stability Refridgerated:

72 hours

Stability Frozen:

30 days

Sample Analyzed: Bronchoalveolar lavage (BAL) fluid

Testing Volume: 3 mL

Pediatric Testing Volume: 1.2 mL

Specimen Transport:

Transport to Laboratory within 2 hours of collection.

Interpretation:

Not detected

Interpretation Type: Expected Results

Test Limitations:

A "Not detected" result may be the result of PCR inhibitors, virus levels below the level of detection of this test, or virus diluted in a large sampling volume. Virus quantitation is not possible due to the nature of the specimen.

Additional Information:

A "Detected" result in BAL specimens indicates the presence of CMV DNA. A result of "Not Detected" in BAL specimens does not rule out the presence of CMV DNA or the absence of infection. False negative results may be due to the suppression of viral replication to levels below the detection threshold, or to inhibitory substances that may be present in the specimen. Inadequate specimen collection, processing and storage may invalidate test results. This test should not be used as the only criterion to form a clinical conclusion, instead, results should be correlated with other test results, patient symptoms and clinical presentation.

 

The performance characteristics of this test were validated by UWHC Clinical Laboratories. The U.S. Food and Drug Administration (FDA) has not approved or cleared this test; however, FDA approval or clearance is currently not required for clinical use of this test. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions. The UWHC Clinical Laboratories is authorized under Clinical Laboratory Improvement Amendments (CLIA) to perform high-complexity testing.